Leary AF - Search Results

1

Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer.

Anderson H, Hills M, Zabaglo L, A'hern R, Leary AF, Haynes BP, Smith IE, Dowsett M. Anderson H, et al. Among authors: leary af. Ann Oncol. 2011 Aug;22(8):1770-6. doi: 10.1093/annonc/mdq700. Epub 2011 Feb 1. Ann Oncol. 2011. PMID: 21285137 Free article.

2

Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials?

Leary A, Smith I. Leary A, et al. Nat Clin Pract Oncol. 2006 Mar;3(3):126-7. doi: 10.1038/ncponc0447. Nat Clin Pract Oncol. 2006. PMID: 16520798 No abstract available.

3

Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?

Leary A, Dowsett M. Leary A, et al. Br J Cancer. 2006 Sep 18;95(6):661-6. doi: 10.1038/sj.bjc.6603316. Epub 2006 Aug 22. Br J Cancer. 2006. PMID: 16926831 Free PMC article. Review.

4

Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients.

O'Brien ME, Borthwick A, Rigg A, Leary A, Assersohn L, Last K, Tan S, Milan S, Tait D, Smith IE. O'Brien ME, et al. Br J Cancer. 2006 Dec 18;95(12):1632-6. doi: 10.1038/sj.bjc.6603498. Br J Cancer. 2006. PMID: 17160081 Free PMC article.

5

Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer.

Johnston SR, Martin LA, Leary A, Head J, Dowsett M. Johnston SR, et al. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):180-6. doi: 10.1016/j.jsbmb.2007.05.019. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17624764 Review.

6

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.

Leary AF, Sirohi B, Johnston SR. Leary AF, et al. Breast Cancer Res. 2007;9(5):112. doi: 10.1186/bcr1763. Breast Cancer Res. 2007. PMID: 17980056 Free PMC article.

7

Enhancing endocrine response with novel targeted therapies: why have the clinical trials to date failed to deliver on the preclinical promise?

Johnston SRD, Leary A, Martin LA, Smith IE, Dowsett M. Johnston SRD, et al. Cancer. 2008 Feb 1;112(3 Suppl):710-717. doi: 10.1002/cncr.23190. Cancer. 2008. PMID: 18072235 Free article.

8

Survival from breast cancer in England and Wales up to 2001.

Leary A, Smith IE. Leary A, et al. Br J Cancer. 2008 Sep 23;99 Suppl 1(Suppl 1):S56-8. doi: 10.1038/sj.bjc.6604588. Br J Cancer. 2008. PMID: 18813261 Free PMC article. No abstract available.

9

ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.

Pancholi S, Lykkesfeldt AE, Hilmi C, Banerjee S, Leary A, Drury S, Johnston S, Dowsett M, Martin LA. Pancholi S, et al. Endocr Relat Cancer. 2008 Dec;15(4):985-1002. doi: 10.1677/ERC-07-0240. Epub 2008 Sep 29. Endocr Relat Cancer. 2008. PMID: 18824559

10

Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients.

Leary AF, Hanna WM, van de Vijver MJ, Penault-Llorca F, Rüschoff J, Osamura RY, Bilous M, Dowsett M. Leary AF, et al. J Clin Oncol. 2009 Apr 1;27(10):1694-705. doi: 10.1200/JCO.2008.17.3989. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255333 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters